Evidence map›Paper›PMID 18045540›Full record

ArticleCell2007

Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues.

Steffen Massberg, Patrick Schaerli, Irina Knezevic-Maramica, Maria Köllnberger, Noah Tubo, E Ashley Moseman, Ines V Huff, Tobias Junt, Amy J Wagers, Irina B Mazo and 1 more

Abstract read
In one paragraph

Article in Cell, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 399 papers.

0numbers the graph read from it
0cells of the map it votes in
399citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

399 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Neutrophils-biology and diversity.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Life science alliance · 2024
    Article

339 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Steffen MassbergImmune Disease Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Patrick Schaerli
Irina Knezevic-Maramica
Maria Köllnberger
Noah Tubo
E Ashley Moseman
Ines V Huff
Tobias Junt
Amy J Wagers
Irina B Mazo
Ulrich H von Andrian

Funding

PREVENTION OF COLD INDUCED PLATELET STORAGE LESIONP01HL056949 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI WAGNER, DENISA D · 1996 to 2010
$26.2M
Virus discovery in cutaneous T cell lymphomaP30AR042689 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUPPER, THOMAS S. · 1994 to 2010
$6.8M
T Cell Activation in Lymph NodesR01AI069259 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2006 to 2015
$4.5M
Migratory Properties of CD8 T CellsR01AI061663 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2004 to 2008
$3.3M
Differentiation and Regulation of CTLR01AI072252 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2007 to 2011
$2.1M
MIGRATORY PROPERTIES OF CD8 T CELLS: IMMUNOLOGY: NODESS10RR021190 · NCRR · IMMUNE DISEASE INSTITUTE, INC. · PI VON ANDRIAN, ULRICH H · 2005 to 2005
$439k
NCRR NIH HHS S10 RR021190NHLBI NIH HHS HL56949NHLBI NIH HHS P01 HL056949NIAID NIH HHS AI061663NIAID NIH HHS R01 AI061663NIAID NIH HHS R01 AI069259NIAID NIH HHS R01 AI072252NIAMS NIH HHS AR42689NIAMS NIH HHS P30 AR042689
6 · The paper itself

Abstract

Constitutive egress of bone marrow (BM)-resident hematopoietic stem and progenitor cells (HSPCs) into the blood is a well-established phenomenon, but the ultimate fate and functional relevance of circulating HSPCs is largely unknown. We show that mouse thoracic duct (TD) lymph contains HSPCs that possess short- and long-term multilineage reconstitution capacity. TD-derived HSPCs originate in the BM, enter the blood, and traffic to multiple peripheral organs, where they reside for at least 36 hr before entering draining lymphatics to return to the blood and, eventually, the BM. HSPC egress from extramedullary tissues into lymph depends on sphingosine-1-phosphate receptors. Migratory HSPCs proliferate within extramedullary tissues and give rise to tissue-resident myeloid cells, preferentially dendritic cells. HSPC differentiation is amplified upon exposure to Toll-like receptor agonists. Thus, HSPCs can survey peripheral organs and can foster the local production of tissue-resident innate immune cells under both steady-state conditions and in response to inflammatory signals.

Indexed as

BloodAnimalsCell MovementDNA-Binding ProteinsFemaleHematopoietic Stem CellsImmunologic SurveillanceLymphatic SystemMaleMiceMice, Inbred C57BLMice, NudeMice, TransgenicModels, BiologicalProto-Oncogene Proteins c-kitReceptors, LysosphingolipidDNA-Binding ProteinsProto-Oncogene Proteins c-kitRag2 protein, mouseReceptors, Lysosphingolipid

Identifiers

PMID18045540
PMCPMC2330270

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.